These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 1027349
1. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes]. Bruni KB, Neirotti R, Albonico G, Gamba S, Regis G, D'Adda A, Soldano E, Bruni B. Ann Osp Maria Vittoria Torino; 1976; 19(16):7-26. PubMed ID: 1027349 [Abstract] [Full Text] [Related]
2. [Clinical experiences with monocomponent insulins]. Bruni Bocher K, Giolitti A, Turco GL, Benedetto P, Bruni B. Minerva Med; 1975 Mar 14; 66(19):909-30. PubMed ID: 1124144 [Abstract] [Full Text] [Related]
3. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology]. Bruni Bocher K, Castellazzi R, D'Adda A, Gamba S, Giolitti A, Rittatore R, Turco GL, Bruni B. Ann Osp Maria Vittoria Torino; 1975 Mar 14; 18(1-6):26-52. PubMed ID: 1242089 [Abstract] [Full Text] [Related]
4. [Pathogenesis of diabetic microangiopathy. Fluoroangioretinal observations during monocomponent insulin therapy]. Anselmetti G, Antoniotti V, Barbero PL, Castellazzi R, Gamba S, Bruni B. Ann Osp Maria Vittoria Torino; 1978 Mar 14; 21(1-6):47-68. PubMed ID: 756200 [Abstract] [Full Text] [Related]
5. [Treatment with monocomponent semi-lente insulin in diabetes of difficult compensation]. Barbero L, Gamba S, Zanno C, Regis G, Bruni B. Minerva Med; 1978 Apr 30; 69(21):1437-42. PubMed ID: 683547 [Abstract] [Full Text] [Related]
10. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin. Wajchenberg BL, Thomsen YG, Toledo e Souza IT, Germek OA. Horm Metab Res; 1986 Aug 30; 18(8):535-9. PubMed ID: 3758926 [Abstract] [Full Text] [Related]
14. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Schernthaner G, Borkenstein M, Fink M, Mayr WR, Menzel J, Schober E. Diabetes Care; 1983 Aug 30; 6 Suppl 1():43-8. PubMed ID: 6343038 [Abstract] [Full Text] [Related]
15. [Serum I-125 insulin IgG binding capacity in diabetic patients on a long-term insulin treatment, with reference to indications for monocomponent insulin therapy]. Bruni B, Castellazzi R, Osenda M, Papotti G, Turco GL. Minerva Med; 1974 Mar 17; 65(20):1071-7. PubMed ID: 4827592 [No Abstract] [Full Text] [Related]
16. Insulin antibodies in diabetics receiving a single type of insulin. Mincu I, Cheţa D. Med Interne; 1982 Mar 17; 20(1):9-13. PubMed ID: 6765628 [Abstract] [Full Text] [Related]
17. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type]. Andreani D, Iavicoli M, Colletti A, Menzinger G. Folia Endocrinol; 1972 Dec 17; 25(6):516-39. PubMed ID: 4581824 [No Abstract] [Full Text] [Related]
20. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Diabetes Care; 2000 Apr 17; 23 Suppl 2():B21-9. PubMed ID: 10860187 [Abstract] [Full Text] [Related] Page: [Next] [New Search]